Skip to content
Nonprofiteer
← INFECTIOUS DISEASES SOCIETY OF AMERICA INC

Form 990 for tax year 2022

Filed by INFECTIOUS DISEASES SOCIETY OF AMERICA INC.

Totals

Total revenue
$34,301,211
Total expenses
$32,853,700
Contributions and grants received
$3,384,750
Grants paid
$893,650
Program service revenue
$29,484,170
Investment income
$830,955
Other revenue
$601,336
Total assets, end of year
$66,632,887
Total liabilities, end of year
$19,191,188
Net assets or fund balances, end of year
$47,441,699
Program services expenses (Part IX)
not reported
Management and general expenses
not reported
Fundraising expenses
not reported
Program service expenses (Part III)
not reported

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1e · Government grants (contributions)

    $3,384,750

  • 2a · Program service revenue: ANNUAL MEETING

    total $14,657,509 · related or exempt $14,657,509

  • 2b · Program service revenue: JOURNALS

    total $9,090,052 · related or exempt $9,090,052

  • 2c · Program service revenue: MEMBERSHIP DUES

    total $2,936,189 · related or exempt $2,936,189

  • 2d · Program service revenue: MANAGEMENT FEES

    total $1,863,617 · related or exempt $1,863,617

  • 2e · Program service revenue: EDUCATION PROGRAMS

    total $838,803 · related or exempt $838,803

  • 2f · All other program service revenue

    total $98,000 · related or exempt $98,000

  • 3 · Investment income

    total $816,196 · excluded $816,196

  • 5 · Royalties

    total $86,161 · excluded $86,161

  • 7a · Gross sales of assets other than inventory

    securities $4,750,000

  • 7b · Less cost or other basis and sales expenses

    securities $4,735,241

  • 7c · Gain or loss

    securities $14,759

  • 7d · Net gain or loss

    total $14,759 · excluded $14,759

  • 11a · Other revenue: CAREER CENTER

    total $294,861 · unrelated business $294,861

  • 11b · Other revenue: WEBSITE ADS

    total $220,314 · unrelated business $220,314

  • 11e · Other revenue, total

    $515,175

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $650,000

  • 2 · Grants to domestic individuals

    total $242,150

  • 3 · Grants to foreign organizations and individuals

    total $1,500

  • 5 · Compensation of officers, directors and key employees

    total $1,943,998

  • 7 · Other salaries and wages

    total $8,978,540

  • 8 · Pension plan contributions

    total $421,452

  • 9 · Other employee benefits

    total $867,554

  • 10 · Payroll taxes

    total $681,466

  • 11b · Fees: legal

    total $26,921

  • 11c · Fees: accounting

    total $57,372

  • 11f · Fees: investment management

    total $138,261

  • 11g · Fees: other

    total $9,248,732

  • 12 · Advertising and promotion

    total $2,637

  • 13 · Office expenses

    total $818,045

  • 14 · Information technology

    total $528,524

  • 16 · Occupancy

    total $907,619

  • 17 · Travel

    total $94,719

  • 19 · Conferences, conventions and meetings

    total $6,773,831

  • 22 · Depreciation, depletion and amortization

    total $323,649

  • 23 · Insurance

    total $146,730

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $5,922,287 · end of year $2,940,822

  • 2 · Savings and temporary cash investments

    beginning of year $705,970 · end of year $1,608,795

  • 4 · Accounts receivable

    beginning of year $3,705,879 · end of year $6,034,144

  • 9 · Prepaid expenses and deferred charges

    beginning of year $339,662 · end of year $741,714

  • 10a · Land, buildings and equipment: cost or other basis

    $4,028,996

  • 10b · Land, buildings and equipment: accumulated depreciation

    $1,764,005

  • 10c · Land, buildings and equipment, net

    beginning of year $2,582,954 · end of year $2,264,991

  • 11 · Investments: publicly traded securities

    beginning of year $50,197,806 · end of year $40,460,434

  • 12 · Investments: other securities

    end of year $4,524,580

  • 15 · Other assets

    beginning of year $789,639 · end of year $8,057,407

  • 17 · Accounts payable and accrued expenses

    beginning of year $2,062,787 · end of year $4,189,557

  • 19 · Deferred revenue

    beginning of year $6,170,401 · end of year $5,001,749

  • 25 · Other liabilities

    beginning of year $2,659,142 · end of year $9,999,882

  • 27 · Net assets without donor restrictions

    beginning of year $53,351,867 · end of year $47,441,699

Mission and programs · 2022

Mission

THE INFECTIOUS DISEASES SOCIETY OF AMERICA (IDSA) IS A COMMUNITY OF OVER 12,000 PHYSICIANS, SCIENTISTS AND PUBLIC HEALTH EXPERTS WHO SPECIALIZE IN INFECTIOUS DISEASES. OUR PURPOSE IS TO IMPROVE THE HEALTH OF INDIVIDUALS, COMMUNITIES, AND SOCIETY BY PROMOTING EXCELLENCE IN PATIENT CARE, EDUCATION, RESEARCH, PUBLIC HEALTH, AND PREVENTION RELATING TO INFECTIOUS DISEASES.

Activities or mission (Part I)

TO PROMOTE EXCELLENCE IN THE PREVENTION AND CARE OF INFECTIOUS DISEASES.

  • IDWEEK ANNUAL CONFERENCE - IN 2022, OVER 10,000 PARTICIPANTS AND EXHIBITORS ATTENDED EITHER IN PERSON OR VIRTUALLY. IDWEEK IS THE WORLD'S PREMIER INFECTIOUS DISEASES EVENT. IDWEEK PROVIDES AN OPPORTUNITY FOR HEALTH PROFESSIONALS OF VARIED BACKGROUNDS TO LEARN FROM EACH OTHER'S KNOWLEDGE, EXPERIENCE AND EXPERTISE, FOR THE IMPROVEMENT OF PATIENT CARE AND PUBLIC HEALTH. THIS IS AN INCLUSIVE MEETING THAT OFFERS ACCESS TO INTERNATIONALLY RECOGNIZED LEADERS IN THE FIELD AND THE OPPORTUNITY TO NETWORK WITH THE MOST HIGHLY RESPECTED HEALTH PROFESSIONALS IN INFECTIOUS DISEASES, INCLUDING HIV.

  • CLINICAL INFECTIOUS DISEASES (CID), THE JOURNAL OF INFECTIOUS DISEASES (JID) AND OPEN FORUM INFECTIOUS DISEASES (OFID) ARE SCHOLARLY JOURNALS PUBLISHED BY IDSA IN PARTNERSHIP WITH AN OUTSIDE PUBLISHER TO DISSEMINATE THE LATEST RESEARCH ON A VARIETY OF TOPICS IN THE FIELD TO MEMBERS AND SUBSCRIBERS. CID PUBLISHES ORIGINAL RESEARCH, REVIEWS AND PERSPECTIVES THAT ALL CLINICIANS CAN USE WHEN CARING FOR PATIENTS. CID COVERS THE CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT AND PREVENTION OF THE FULL RANGE OF INFECTIOUS DISEASES. THE EVALUATION OF CURRENT AND NOVEL TREATMENTS, MICROBIOLOGY, IMMUNOLOGY AND POLICIES AS THEY RELATE TO PATIENT CARE ARE HIGHLY PRIORITIZED. PUBLISHED CONTINUOUSLY SINCE 1904, JID IS THE PREMIER GLOBAL JOURNAL FOR TRANSLATIONAL INFECTIOUS DISEASES SCIENCE. THE EDITORS WELCOME MAJOR ARTICLES AND BRIEF REPORTS DESCRIBING RESEARCH RESULTS ON MICROBIOLOGY, IMMUNOLOGY, EPIDEMIOLOGY, AND RELATED DISCIPLINES, ON THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF INFECTIOUS DISEASES; ON THE MICROBES THAT CAUSE THEM; AND ON DISORDERS OF HOST IMMUNE RESPONSES. OFID PUBLISHES CLINICAL, TRANSLATIONAL AND BASIC RESEARCH IN A FULLY OPEN ACCESS, ONLINE JOURNAL. IT FOCUSES ON THE INTERSECTION OF BIOMEDICAL SCIENCE AND CLINICAL PRACTICE, WITH AN EMPHASIS ON KNOWLEDGE THAT COULD IMPROVE PATIENT CARE GLOBALLY. ARTICLES ARE WRITTEN BY EXPERTS IN THE FIELD, INCLUDING MEMBERS AND NON-MEMBERS, AND REVIEWED BY A PANEL OF LEADING MEDICAL EXPERTS BEFORE THEY ARE PUBLISHED.

  • IDSA WAS AWARDED A COOPERATIVE AGREEMENT TO SUPPORT THE CDC BY PROVIDING RESOURCES TO FRONTLINE HEALTH CARE PROFESSIONALS CARING FOR PATIENTS WITH COVID-19. THE PARTNERSHIP BRINGS NUMEROUS MEDICAL SPECIALTIES TOGETHER TO SHARE RESOURCES AND TO PROVIDE THE LATEST INFORMATION AND GUIDANCE ON TREATING THOSE INFECTED WITH COVID-19 AND PREVENTING ITS SPREAD. THROUGH FUNDING FROM CDC, IDSA EXPERTS SUPPORT CDC'S CLINICAL CALL LINES, PROVIDING GUIDANCE TO HEALTH CARE PROVIDERS TREATING COVID-19 PATIENTS. THE COLLABORATION HAS ALSO FUNDED THE FLOURISHING COVID-19 REAL-TIME LEARNING NETWORK, AN ONLINE CENTER FOR FRONTLINE CLINICIANS TO LEARN, COLLABORATE AND SHARE TREATMENT BEST PRACTICES. IDSA'S COVID-19 PRACTICE GUIDELINES ON DIAGNOSTICS, TREATMENT AND MANAGEMENT ALSO RECEIVE FUNDING THROUGH THE GRANT. ADDITIONALLY, UNDER THE PARTNERSHIP, TWICE-MONTHLY CLINICIAN TELECONFERENCES PROVIDE HEALTH CARE PROFESSIONALS ACCESS TO EXPERTS WITH THE LATEST INFORMATION ON THIS EVOLVING VIRUS AS WELL AS AN OPPORTUNITY TO ASK QUESTIONS. THE CALLS FREQUENTLY DRAW MORE THAN 800 ATTENDEES.

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Chris Busky

    CEO

    Total calculated
    $649,548
    From this org
    $563,970
    From related orgs
    $31,773
    Other
    $53,805
    Hours/week
    35.5 + 2 related

    Schedule J breakdown matched by us

    Base
    $444,192 + $25,025 related
    Bonus
    $119,778 + $6,748 related
    Other
    $0
    Deferred
    $43,197 + $2,434 related
    Nontaxable benefits
    $7,738 + $436 related
    Filer's total
    $614,905 + $34,643 related
  • Ty Johnson

    COO (START DATE OF 4-1-22)

    Total calculated
    $292,117
    From this org
    $188,373
    From related orgs
    $94,186
    Other
    $9,558
    Hours/week
    25 + 12.5 related

    Schedule J breakdown matched by us

    Base
    $155,527 + $77,763 related
    Bonus
    $32,846 + $16,423 related
    Other
    $0
    Deferred
    $6,301 + $3,150 related
    Nontaxable benefits
    $0 + $107 related
    Filer's total
    $194,674 + $97,443 related
  • Sandra Vura Harwood

    VP, MTG. EDU.

    Total calculated
    $288,021
    From this org
    $268,031
    From related orgs
    $0
    Other
    $19,990
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $248,031
    Bonus
    $20,000
    Other
    $0
    Deferred
    $13,874
    Nontaxable benefits
    $6,116
    Filer's total
    $288,021
  • Dana Wollins

    VP, CLINICAL AFFR. & GUIDE

    Total calculated
    $284,454
    From this org
    $261,409
    From related orgs
    $0
    Other
    $23,045
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $241,409
    Bonus
    $20,000
    Other
    $0
    Deferred
    $13,673
    Nontaxable benefits
    $9,372
    Filer's total
    $284,454
  • Amanda Jezek

    SVP, POLICY & GOV. REL.

    Total calculated
    $284,424
    From this org
    $262,642
    From related orgs
    $0
    Other
    $21,782
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $242,642
    Bonus
    $20,000
    Other
    $0
    Deferred
    $13,628
    Nontaxable benefits
    $8,154
    Filer's total
    $284,424
  • Felicity Clancy

    VP, MKT. / MEMBE.

    Total calculated
    $257,210
    From this org
    $236,730
    From related orgs
    $0
    Other
    $20,480
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $216,730
    Bonus
    $20,000
    Other
    $0
    Deferred
    $12,328
    Nontaxable benefits
    $8,152
    Filer's total
    $257,210
  • Barton Groh

    VP, FIN. & ADMIN

    Total calculated
    $253,693
    From this org
    $227,939
    From related orgs
    $7,474
    Other
    $18,280
    Hours/week
    30.5 + 1 related

    Schedule J breakdown matched by us

    Base
    $208,574 + $6,839 related
    Bonus
    $19,365 + $635 related
    Other
    $0
    Deferred
    $11,685 + $383 related
    Nontaxable benefits
    $6,015 + $197 related
    Filer's total
    $245,639 + $8,054 related
  • Salandra Thomas

    VP, TALENT / ORGA. DEVEL.

    Total calculated
    $252,703
    From this org
    $230,475
    From related orgs
    $6,653
    Other
    $15,575
    Hours/week
    34.5 + 1 related

    Schedule J breakdown matched by us

    Base
    $211,038 + $6,117 related
    Bonus
    $19,437 + $536 related
    Other
    $0
    Deferred
    $11,658 + $338 related
    Nontaxable benefits
    $3,478 + $101 related
    Filer's total
    $245,611 + $7,092 related
  • Andrea Weddle

    ED, HIVMA

    Total calculated
    $241,937
    From this org
    $220,384
    From related orgs
    $6,038
    Other
    $15,515
    Hours/week
    36.5 + 1 related

    Schedule J breakdown matched by us

    Base
    $200,917 + $5,505 related
    Bonus
    $19,467 + $533 related
    Other
    $0
    Deferred
    $11,180 + $306 related
    Nontaxable benefits
    $3,922 + $107 related
    Filer's total
    $235,486 + $6,451 related
  • Michael Cummins

    SR DIR, PROJECT MANAGEMENT AND GRANTS

    Total calculated
    $201,518
    From this org
    $185,087
    From related orgs
    $0
    Other
    $16,431
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $162,267
    Bonus
    $22,820
    Other
    $0
    Deferred
    $9,358
    Nontaxable benefits
    $7,073
    Filer's total
    $201,518
  • Rachel Shnekendorf

    SR DIR, EDUCATION

    Total calculated
    $182,762
    From this org
    $170,319
    From related orgs
    $0
    Other
    $12,443
    Hours/week
    37.5

    Schedule J breakdown matched by us

    Base
    $167,472
    Bonus
    $2,847
    Other
    $0
    Deferred
    $8,869
    Nontaxable benefits
    $3,574
    Filer's total
    $182,762
  • Carlos Del Rio MD Fidsa

    PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Steven K Schmitt MD Fidsa

    PRESIDENT-ELECT

    Total calculated
    $0
    Hours/week
    2
  • Tina Q Tan MD Fidsa

    VICE PRESIDENT

    Total calculated
    $0
    Hours/week
    2
  • Jeffrey S Duchin MD Fidsa

    SECRETARY

    Total calculated
    $0
    Hours/week
    2
  • Jeanne Marrazzo MD Fidsa

    TREASURER

    Total calculated
    $0
    Hours/week
    2 + 2 related
  • Dan P McQuillen MD Fidsa

    IMMEDIATE PAST PRESIDENT

    Total calculated
    $5,000
    From this org
    $5,000
    From related orgs
    $0
    Other
    $0
    Hours/week
    2
  • Lilian M Abbo MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Adaora A Adimora MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Cesar A Arias MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Wendy Armstrong MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Maximo O Brito MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Rana Chakraborty MD Msc Dphil Fid

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Rajesh T Ghandi MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Jasmine Marcelin MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Robin Trottman Do Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Bonnie M Word MD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Angela M Calendo MD PhD Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Barbara Alexander MD Mhs Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • Kimberly E Hanson MD

    MEMBER

    Total calculated
    $0
    Hours/week
    2
  • John B Lynch II MD MPH Fidsa

    MEMBER

    Total calculated
    $0
    Hours/week
    2

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement

The filer's explanations (Part III)

PART I, LINE 3
CEO COMPENSATION: THE IDSA BOARD HAS ENTERED INTO AN EMPLOYMENT CONTRACT WITH ITS CHIEF EXECUTIVE OFFICER. THE COMPENSATION DETAILED IN THE CONTRACT AND SUBSEQUENT RAISES DURING THE CONTRACT TERM ARE BASED ON A REVIEW OF 990'S FROM OTHER SIMILAR NON-PROFIT ORGANIZATIONS, A COMPENSATION STUDY WRITTEN EMPLOYMENT CONTRACTS OF OTHER SIMILARILY SITUATED EXCECUTIVES, AND ANNUAL APPROVAL BY THE EXECUTIVE COMMITTEE.
PART I, LINE 4B
THE ORGANIZATION CONTRIBUTED $29,598 TO 457 PLANS FOR THE BENEFIT OF THE CEO.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • IDSA EDUCATION AND RESEARCH FOUNDATION

    501(C)(3) · FUNDING INITIATIVES DEDICATED TO SUPPORTING IDSA'S MISSION WORLDWIDE · VA · controlled entity

    Directly controlled by INFECTIOUS DISEASES SOCIETY OF AMERICA

Provenance

Return type
form_990
Tax year
2022
Filed
8 November 2023
IRS schema version
2022v5.0
Source object
202303139349306110

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.